Beneficial effects of 15-deoxyspergualin on late acute rejection occurring more than three months after renal transplantation.
Department of Surgery, Sendai Shakaihoken Hospital, Japan.
N
N
Amada
H
H
Okazaki
T
T
Sato
S
S
Miura
Y
Y
Ohashi
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use*; D012008:Recurrence; D013997:Time Factors
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus; D008775:Methylprednisolone